LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Putative surface antigen protein 2

Quick info Annotations Function or PPIs Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Putative surface antigen protein 2
Gene product:
hypothetical protein - conserved
Species:
Leishmania infantum
UniProt:
E9AGG5_LEIIN
TriTrypDb:
LINF_120014400
Length:
417

Annotations

LeishMANIAdb annotations

Publication identifier(s): 8702946
A surface coat protein involved in immune evasion in Leishmaniids. Extremely fast evolving, almost completely disordered mucin-like protein. . Localization: Cell surface (experimental)

LeishMANIAdb interaction annotations

by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role

Annotations by Jardim et al.

Plasma membrane, surface antigen 2 LINJ.12.0666

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. yes yes: 155
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 7
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 14
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 yes yes: 62, no: 8
NetGPI no yes: 0, no: 70
Cellular components
Term Name Level Count
GO:0005929 cilium 4 71
GO:0042995 cell projection 2 71
GO:0043226 organelle 2 71
GO:0043227 membrane-bounded organelle 3 71
GO:0110165 cellular anatomical entity 1 71
GO:0120025 plasma membrane bounded cell projection 3 71
GO:0016020 membrane 2 25
GO:0005886 plasma membrane 3 3

Expansion

Sequence features

E9AGG5
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: E9AGG5

Function

Could not find GO biological_process term for this entry.
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 1
GO:0004672 protein kinase activity 3 1
GO:0004674 protein serine/threonine kinase activity 4 1
GO:0016301 kinase activity 4 1
GO:0016740 transferase activity 2 1
GO:0016772 transferase activity, transferring phosphorus-containing groups 3 1
GO:0016773 phosphotransferase activity, alcohol group as acceptor 4 1
GO:0140096 catalytic activity, acting on a protein 2 1

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_NRD_NRD_1 277 279 PF00675 0.508
CLV_NRD_NRD_1 6 8 PF00675 0.732
CLV_PCSK_KEX2_1 277 279 PF00082 0.523
CLV_PCSK_KEX2_1 316 318 PF00082 0.652
CLV_PCSK_KEX2_1 6 8 PF00082 0.732
CLV_PCSK_PC1ET2_1 277 279 PF00082 0.523
CLV_PCSK_PC1ET2_1 316 318 PF00082 0.638
CLV_PCSK_SKI1_1 257 261 PF00082 0.550
CLV_PCSK_SKI1_1 31 35 PF00082 0.720
CLV_PCSK_SKI1_1 7 11 PF00082 0.748
DEG_SCF_FBW7_2 345 350 PF00400 0.444
DEG_SPOP_SBC_1 303 307 PF00917 0.643
DEG_SPOP_SBC_1 320 324 PF00917 0.433
DOC_CYCLIN_RxL_1 3 13 PF00134 0.466
DOC_MAPK_gen_1 277 284 PF00069 0.311
DOC_MAPK_MEF2A_6 277 284 PF00069 0.359
DOC_USP7_MATH_1 318 322 PF00917 0.475
DOC_USP7_MATH_2 199 205 PF00917 0.349
DOC_USP7_UBL2_3 294 298 PF12436 0.346
DOC_USP7_UBL2_3 61 65 PF12436 0.294
DOC_WW_Pin1_4 337 342 PF00397 0.576
DOC_WW_Pin1_4 343 348 PF00397 0.511
LIG_Actin_WH2_2 177 192 PF00022 0.274
LIG_BIR_II_1 1 5 PF00653 0.664
LIG_FHA_1 103 109 PF00498 0.336
LIG_FHA_1 131 137 PF00498 0.336
LIG_FHA_1 145 151 PF00498 0.438
LIG_FHA_1 184 190 PF00498 0.321
LIG_FHA_1 325 331 PF00498 0.436
LIG_FHA_1 44 50 PF00498 0.457
LIG_FHA_2 108 114 PF00498 0.327
LIG_FHA_2 207 213 PF00498 0.382
LIG_FHA_2 349 355 PF00498 0.502
LIG_LIR_Gen_1 103 112 PF02991 0.429
LIG_LIR_Gen_1 128 136 PF02991 0.338
LIG_LIR_Gen_1 153 160 PF02991 0.431
LIG_LIR_Gen_1 200 210 PF02991 0.318
LIG_LIR_Gen_1 248 256 PF02991 0.402
LIG_LIR_Nem_3 103 107 PF02991 0.437
LIG_LIR_Nem_3 71 75 PF02991 0.358
LIG_PCNA_PIPBox_1 132 141 PF02747 0.264
LIG_PDZ_Class_2 412 417 PF00595 0.283
LIG_Pex14_1 72 76 PF04695 0.245
LIG_SH2_CRK 104 108 PF00017 0.481
LIG_SH2_CRK 76 80 PF00017 0.268
LIG_SH2_GRB2like 104 107 PF00017 0.273
LIG_SH2_STAP1 104 108 PF00017 0.280
LIG_SH2_STAT5 104 107 PF00017 0.400
LIG_SH2_STAT5 376 379 PF00017 0.324
LIG_SH2_STAT5 74 77 PF00017 0.376
LIG_SH3_1 298 304 PF00018 0.387
LIG_SH3_3 298 304 PF00018 0.393
LIG_SH3_3 329 335 PF00018 0.581
LIG_SH3_3 93 99 PF00018 0.427
LIG_SUMO_SIM_anti_2 206 212 PF11976 0.277
LIG_SUMO_SIM_anti_2 46 51 PF11976 0.312
LIG_SUMO_SIM_par_1 280 285 PF11976 0.321
LIG_TYR_ITIM 102 107 PF00017 0.351
LIG_UBA3_1 210 217 PF00899 0.296
MOD_CK1_1 128 134 PF00069 0.413
MOD_CK1_1 153 159 PF00069 0.486
MOD_CK1_1 179 185 PF00069 0.385
MOD_CK1_1 197 203 PF00069 0.351
MOD_CK1_1 204 210 PF00069 0.363
MOD_CK1_1 221 227 PF00069 0.426
MOD_CK1_1 245 251 PF00069 0.351
MOD_CK1_1 312 318 PF00069 0.459
MOD_CK1_1 321 327 PF00069 0.445
MOD_CK1_1 380 386 PF00069 0.355
MOD_CK2_1 348 354 PF00069 0.544
MOD_CK2_1 91 97 PF00069 0.415
MOD_GlcNHglycan 113 117 PF01048 0.588
MOD_GlcNHglycan 121 124 PF01048 0.583
MOD_GlcNHglycan 170 173 PF01048 0.551
MOD_GlcNHglycan 194 197 PF01048 0.633
MOD_GlcNHglycan 218 221 PF01048 0.641
MOD_GlcNHglycan 225 229 PF01048 0.605
MOD_GlcNHglycan 230 233 PF01048 0.571
MOD_GlcNHglycan 241 245 PF01048 0.526
MOD_GlcNHglycan 25 28 PF01048 0.764
MOD_GlcNHglycan 250 253 PF01048 0.561
MOD_GlcNHglycan 261 264 PF01048 0.554
MOD_GlcNHglycan 362 367 PF01048 0.724
MOD_GlcNHglycan 396 399 PF01048 0.290
MOD_GlcNHglycan 79 82 PF01048 0.591
MOD_GSK3_1 121 128 PF00069 0.435
MOD_GSK3_1 130 137 PF00069 0.374
MOD_GSK3_1 146 153 PF00069 0.456
MOD_GSK3_1 176 183 PF00069 0.367
MOD_GSK3_1 185 192 PF00069 0.324
MOD_GSK3_1 197 204 PF00069 0.354
MOD_GSK3_1 224 231 PF00069 0.403
MOD_GSK3_1 242 249 PF00069 0.353
MOD_GSK3_1 302 309 PF00069 0.508
MOD_GSK3_1 312 319 PF00069 0.483
MOD_GSK3_1 320 327 PF00069 0.475
MOD_GSK3_1 330 337 PF00069 0.627
MOD_GSK3_1 339 346 PF00069 0.521
MOD_GSK3_1 376 383 PF00069 0.448
MOD_N-GLC_1 36 41 PF02516 0.591
MOD_N-GLC_2 297 299 PF02516 0.686
MOD_NEK2_1 10 15 PF00069 0.528
MOD_NEK2_1 112 117 PF00069 0.444
MOD_NEK2_1 121 126 PF00069 0.410
MOD_NEK2_1 165 170 PF00069 0.341
MOD_NEK2_1 189 194 PF00069 0.420
MOD_NEK2_1 21 26 PF00069 0.528
MOD_NEK2_1 213 218 PF00069 0.317
MOD_NEK2_1 242 247 PF00069 0.365
MOD_NEK2_1 38 43 PF00069 0.361
MOD_NEK2_2 185 190 PF00069 0.363
MOD_PIKK_1 107 113 PF00454 0.252
MOD_PIKK_1 165 171 PF00454 0.326
MOD_PIKK_1 38 44 PF00454 0.311
MOD_PKA_1 316 322 PF00069 0.431
MOD_PKA_2 119 125 PF00069 0.295
MOD_PKA_2 144 150 PF00069 0.444
MOD_PKA_2 189 195 PF00069 0.281
MOD_PKA_2 316 322 PF00069 0.439
MOD_Plk_1 200 206 PF00069 0.357
MOD_Plk_1 380 386 PF00069 0.445
MOD_Plk_4 131 137 PF00069 0.372
MOD_Plk_4 206 212 PF00069 0.365
MOD_ProDKin_1 337 343 PF00069 0.573
TRG_DiLeu_BaEn_1 381 386 PF01217 0.319
TRG_ENDOCYTIC_2 104 107 PF00928 0.500
TRG_ER_diArg_1 5 7 PF00400 0.658
TRG_Pf-PMV_PEXEL_1 55 59 PF00026 0.512

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1I121 Leptomonas seymouri 30% 83%
A0A0N1I7S5 Leptomonas seymouri 30% 82%
A0A0S4IZC7 Bodo saltans 25% 100%
A0A0S4J206 Bodo saltans 31% 68%
A0A0S4JB17 Bodo saltans 29% 67%
A0A0S4JEP2 Bodo saltans 21% 72%
A0A0S4KK37 Bodo saltans 25% 72%
A0A0S4KMS7 Bodo saltans 27% 100%
A0A3Q8I9A6 Leishmania donovani 81% 100%
A0A3Q8I9B4 Leishmania donovani 59% 67%
A0A3Q8I9D0 Leishmania donovani 60% 100%
A0A3Q8I9D9 Leishmania donovani 59% 66%
A0A3Q8IFC2 Leishmania donovani 38% 96%
A0A3Q8IIJ9 Leishmania donovani 30% 100%
A0A3S5H6D6 Leishmania donovani 30% 100%
A0A3S5H6L9 Leishmania donovani 59% 72%
A0A3S7WP69 Leishmania donovani 24% 100%
A0A3S7WPB2 Leishmania donovani 24% 100%
A0A3S7X4J4 Leishmania donovani 33% 100%
A4H4D2 Leishmania braziliensis 23% 100%
A4H4G6 Leishmania braziliensis 24% 100%
A4H5P0 Leishmania braziliensis 29% 100%
A4HBX3 Leishmania braziliensis 31% 92%
A4HJC8 Leishmania braziliensis 34% 100%
A4HSL2 Leishmania infantum 24% 100%
A4HTX9 Leishmania infantum 28% 100%
A4HVB0 Leishmania infantum 53% 100%
A4I6S2 Leishmania infantum 35% 100%
A4I6S3 Leishmania infantum 39% 83%
A4I6S4 Leishmania infantum 32% 100%
D1GJ51 Leishmania infantum 53% 90%
E8NHG5 Leishmania mexicana (strain MHOM/GT/2001/U1103) 38% 94%
E8NHP8 Leishmania mexicana (strain MHOM/GT/2001/U1103) 31% 100%
E9ACQ0 Leishmania major 24% 100%
E9AG65 Leishmania infantum 24% 100%
E9AGG7 Leishmania infantum 41% 67%
E9AGG9 Leishmania infantum 44% 77%
E9AGH0 Leishmania infantum 76% 100%
E9AKM8 Leishmania mexicana (strain MHOM/GT/2001/U1103) 25% 100%
E9AMQ9 Leishmania mexicana (strain MHOM/GT/2001/U1103) 29% 100%
E9AP02 Leishmania mexicana (strain MHOM/GT/2001/U1103) 58% 86%
E9AP03 Leishmania mexicana (strain MHOM/GT/2001/U1103) 63% 93%
E9AP05 Leishmania mexicana (strain MHOM/GT/2001/U1103) 48% 81%
E9AP07 Leishmania mexicana (strain MHOM/GT/2001/U1103) 59% 87%
E9AP08 Leishmania mexicana (strain MHOM/GT/2001/U1103) 68% 100%
E9AVA1 Leishmania mexicana (strain MHOM/GT/2001/U1103) 36% 90%
E9B1U4 Leishmania mexicana (strain MHOM/GT/2001/U1103) 35% 100%
E9B1U5 Leishmania mexicana (strain MHOM/GT/2001/U1103) 40% 100%
E9B1U6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 31% 100%
Q25331 Leishmania major 56% 89%
Q4Q6B6 Leishmania major 34% 100%
Q4Q6B7 Leishmania major 33% 100%
Q4Q6B8 Leishmania major 35% 79%
Q4QGI0 Leishmania major 47% 82%
Q4QGI2 Leishmania major 48% 74%
Q4QGI4 Leishmania major 46% 78%
Q4QGI6 Leishmania major 61% 76%
Q4QGJ0 Leishmania major 52% 66%
Q4QGJ4 Leishmania major 56% 89%
Q4QGJ6 Leishmania major 49% 73%
Q4QGJ7 Leishmania major 57% 89%
Q4QGJ9 Leishmania major 51% 71%
Q4QGK2 Leishmania major 51% 74%
Q4QGK6 Leishmania major 56% 89%
Q4QGL4 Leishmania major 55% 90%
Q4QGL5 Leishmania major 49% 76%
Q4QGL8 Leishmania major 56% 68%
Q4QHW6 Leishmania major 29% 100%
Q4QJB2 Leishmania major 21% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS